A spurious description of hyperfixation of HMPAO.
Patterson
J
J
Wyper
D J
DJ
Hadley
D M
DM
D002544:Cerebral Infarction / Q000000981:diagnostic imaging / Q000378:metabolism; D002561:Cerebrovascular Disorders / Q000000981:diagnostic imaging* / Q000378:metabolism; D005500:Follow-Up Studies; D006801:Humans; D006940:Hyperemia / Q000000981:diagnostic imaging / Q000378:metabolism; D002542:Intracranial Embolism and Thrombosis / Q000000981:diagnostic imaging* / Q000378:metabolism; D015609:Organotechnetium Compounds / Q000493:pharmacokinetics; D010091:Oximes / Q000493:pharmacokinetics; D010960:Plasminogen Activators / Q000627:therapeutic use; D015424:Reperfusion; D019690:Technetium Tc 99m Exametazime; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use; D015899:Tomography, Emission-Computed, Single-Photon
D015609:Organotechnetium Compounds; D010091:Oximes; D019690:Technetium Tc 99m Exametazime; D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator